As vaccines continue to roll out, many have forgotten our original first line of defense for COVID: the antibody treatment. Monoclonal antibodies are produced in laboratories where scientists copy antibodies targeted to combat COVID.
These cells are retrieved from people who formerly had COVID and still have the antibodies in their system. This one cell is then replicated and inserted into other patients to develop their immune system to fight COVID.
While this may seem to put at-risk patients in vulnerable situations, healthcare professionals recommend the treatment for those concerned with contracting COVID. Moreover, the Mayo clinic actually encourages at-risk COVID patients to consider the treatment.
Now that the COVID vaccine is available, some may feel that the antibody treatment is not as effective. However, for those with underlying conditions and unvaccinated, these treatments could prevent hospitalization upon contraction of the virus.
While vaccination, social distancing, and masking help prevent the spread; the antibody treatment can save the life of those with conditions like high blood pressure, diabetes, obesity, etc.
But what factors should you consider before getting the antibody treatment? Like all medical treatments, it’s important to do your own research and talk with healthcare professionals before pursuing a specific treatment. However, here are items to consider before deciding on the COVID antibody treatment.
Cost & Eligibility
The upfront cost of the COVID antibody treatment is $1250. However, the federal government is offering it for free for eligible patients.
While the actual treatment is no cost, healthcare facilities may charge for the infusion.